<DOC>
	<DOCNO>NCT00944996</DOCNO>
	<brief_summary>The neuropeptide Pituitary Adenylate Cyclase Activating Polypeptide ( PACAP ) receptor PAC1 VPAC2 widely express nervous system . The investigator find PACAP treatment neuronal cell culture increase expression Brain Derived Neurotrophic Factor ( BDNF ) play important role etiology psychiatric disorder action antidepressant . For first time , investigator demonstrate treatment Paroxetine Citalopram significantly decrease PAC1 VPAC2 upregulates PACAP mRNA expression , whereas Imipramine show opposite effect . Moreover , PACAP , PAC1 VPAC2 expression highly correlate BDNF expression . Their vivo study show Imipramine reduce BDNF increase PAC1 mRNA expression murine hippocampus , suggest antidepressant may affect neuronal plasticity PACAP-BDNF interaction . Based observation experimental system , investigator hypothesize PACAP signal system may involve etiology depression mechanism antidepressant action . The investigator evaluate hypothesis examine serum PACAP level , effect antidepressant PACAP level , gene polymorphism PACAP receptor major depressive disorder patient . This study enhance investigator ' understand PACAP 's role etiology depression antidepressant treatment provide basis evaluate PACAP pathway potential target diagnostics novel antidepressant drug discovery .</brief_summary>
	<brief_title>Assessment Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor ( PACAP-BDNF ) Signaling System Involvement Etiology Treatment Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Pituitary Adenylate Cyclase-Activating Polypeptide</mesh_term>
	<criteria>1 . Men woman 1865 age old 2 . Patients DSMIV ( or/and ICD10 ) diagnosis MDD 3 . Volunteers without DSMIV ( or/and ICD10 ) diagnosis MDD 4 . For patient DSMIV ( or/and ICD10 ) diagnosis MDD minimum 2 week free benzodiazepine , mood stabilizer neuroleptic . 5 . All patient MDD group treatment SSRI antidepressant medication . 1 . MDD Comorbidity 2 . Alcohol drug use le 1 month study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>PACAP ( Pituitary Adenylate Cyclase Activating Polypeptide )</keyword>
	<keyword>Major Depression</keyword>
	<keyword>Receptors</keyword>
	<keyword>Gene polymorphism</keyword>
	<keyword>PACAP signal system</keyword>
	<keyword>Etiology major depression</keyword>
	<keyword>Mechanism antidepressant action</keyword>
	<keyword>PACAP receptor gene polymorphism</keyword>
	<keyword>Pathogenesis major depression</keyword>
	<keyword>Responsiveness antidepressant drug</keyword>
</DOC>